1. Cancer statistics, 2012;Siegel;Ca Cancer J Clin,2012
2. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010
3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010
4. abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011
5. Effect of MDV3100, an androgen receptor signaling inhibitor (aRSI), on overall survival in patients with prostate cancer postdocetaxel: results from the phase III aFFIRM study;Scher;Proc annu Meet am Soc Clin Oncol,2012